Retrieved from Usach, I., Martinez, R., Festini, T., & Peris, J
Transform Your Health
Tamoxifen vs aromatase inhibitors: a quick overview Both treatments are used for hormone receptor-positive breast cancer Tamoxifen blocks oestrogen receptors on cancer cells Aromatase inhibitors reduce oestrogen production in the body Choice of treatment depends on menopausal status and clinical factors Hormone receptor positive breast cancer About 75% of breast cancers are positive for the oestrogen receptor (ER) and/or progesterone receptor (PR) 1,2,3
Our company is in accordance with the requirements of this standard and continued to handle, store, transport and export our line of Edible Products
Additionally, both medications can influence fluid and electrolyte balance, though through different mechanisms
doi: 10.1038/s41574-021-00507-z 94 PromratKKleinerDENiemeierHMJackvonyEKearnsMWandsJRet al